Esperion Therapeutics CEO Tim Mayleben's 2021 pay rises 19% to $8.2M
Esperion Therapeutics reports 2021 executive compensation
By ExecPay News
Published: April 14, 2022
Esperion Therapeutics reported fiscal year 2021 executive compensation information on April 14, 2022.
In 2021, five executives at Esperion Therapeutics received on average a compensation package of $5.2M, a 77% increase compared to previous year.
Average pay of disclosed executives at Esperion Therapeutics
Tim M. Mayleben, Chief Executive Officer, received $8.2M in total, which increased by 19% compared to 2020. 48% of Mayleben's compensation, or $4M, was in option awards. Mayleben also received $265K in salary and $4M in other compensation.
For fiscal year 2021, the median employee pay was $217,116 at Esperion Therapeutics. Therefore, the ratio of Tim M. Mayleben's pay to the median employee pay was 38 to one.
Sheldon L. Koenig, Chief Executive Officer, received a compensation package of $7.8M, which increased by 33444% compared to previous year. 70% of the compensation package, or $5.4M, was in option awards.
JoAnne Foody, Chief Medical Officer, earned $3.7M in 2021.
Richard B. Bartram, Chief Financial Officer, received $3.3M in 2021, which increases by 35% compared to 2020.
Ashley Hall, Former Chief Development Officer, earned $2.9M in 2021, a 25% increase compared to previous year.
Related executives
You may also like
Source: SEC filing on April 14, 2022.